Your session is about to expire
← Back to Search
Procedure
Wavefront optimized Photorefractive Keratectomy for Near-sightedness
N/A
Waitlist Available
Led By Mark Mifflin, MD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This trial will compare the results of two different types of laser vision correction surgeries.
Eligible Conditions
- Near-sightedness
- Surgery
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Uncorrected Visual Acuity From Baseline to Month 12
Secondary outcome measures
Change in Contrast Sensitivity From Baseline to Month 3
Other outcome measures
Change in Quality of Life Score From Baseline to 3 Months
Trial Design
4Treatment groups
Active Control
Group I: Wavefront optimized Photorefractive KeratectomyActive Control2 Interventions
Participants who chose to have Photorefractive Keratectomy surgery were assigned to have Wavefront optimized Photorefractive Keratectomy in one eye and Topography-guided Photorefractive Keratectomy in the other eye (randomly chosen).
Group II: Topography-guided LASIKActive Control2 Interventions
Participants who chose to have LASIK surgery were assigned to have Topography-guided LASIK in one eye and Wavefront optimized LASIK in the other eye (randomly chosen).
Group III: Wavefront optimized LASIKActive Control2 Interventions
Participants who chose to have LASIK surgery were assigned to have Wavefront optimized LASIK in one eye and Topography-guided LASIK in the other eye (randomly chosen).
Group IV: Topography-guided Photorefractive KeratectomyActive Control2 Interventions
Participants who chose to have Photorefractive Keratectomy surgery were assigned to have Topography-guided Photorefractive Keratectomy in one eye and Wavefront optimized Photorefractive Keratectomy in the other eye (randomly chosen).
Find a Location
Who is running the clinical trial?
University of UtahLead Sponsor
1,099 Previous Clinical Trials
1,778,650 Total Patients Enrolled
Mark Mifflin, MDPrincipal Investigator - University of Utah Moran Eye Center
LDS Hospital, Primary Children's Hospital, University of Utah Hospital
University Of Nevada School Of Medicine (Medical School)
University Of Ut Medical Center (Residency)
2 Previous Clinical Trials
175 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger